Thursday, November 16, 2023
4:00 PM - 4:30 PM
Marriott Grand Ballroom Foyer - Poster Station 5
E-poster Session 5 - Male Medical
Moderator:
Kevin Campbell, MD, MS
4:00 PM - 4:03 PM
Use of Bremelanotide (Vyleesi) in Men with Sexual Dysfunctions (#235)
Speaker:
Sue Goldstein, BA, CCRC, AASECT-CSE, IF
4:03 PM - 4:06 PM
Evaluating the Social Media Landscape Surrounding Men’s Health Conditions in Testicular Cancer Patients (#236)
Speaker:
Nick Winokur
4:06 PM - 4:09 PM
The Representation of Minority Men in a Restorative Therapy Clinical Trial for Erectile Dysfunction (#237)
Speaker:
Armin Ghomeshi
4:09 PM - 4:12 PM
Changing Landscape of Erectile Dysfunction: Shift in Risk Factors and Presentation Patterns (#238)
Speaker:
Taher Naeem
4:12 PM - 4:15 PM
Stem Cell Therapy for Erectile Dysfunction Across States – Fact or Fiction? (#239)
Speaker:
Muhammed A Moukhtar Hammad
4:15 PM - 4:18 PM
Evaluation of Factors Associated with Reoperation Rates for Penile Prosthetic Implantation in Erectile Dysfunction: A Medicare Analysis (#240)
Speaker:
Navid Leelani
4:18 PM - 4:21 PM
Optimizing Care - Economic Impact of Reduced Teaching Visits After IPP Implantation (#241)
Speaker:
Bradley Gill
4:21 PM - 4:24 PM
Medicare Beneficiaries with Erectile Dysfunction Who Receive Inflatable Penile Prosthesis: A Real-World, Downstream Revenue Analysis (#242)
Speaker:
Andrew Sun
4:24 PM - 4:27 PM
Frenular Delta Excision with Neurectomy of Ventro – Lateral Branches of Penile Dorsal Nerves (Alaa Aglan4 Operation) (#243)
Speaker:
Alaa Aglan
4:27 PM - 4:30 PM
Participants with Penile Pain at Baseline May Benefit from Collagenase Clostridium Histolyticum Treatment: A Post Hoc Analysis (#244)
Speaker:
Jesse Mills, MD
Friday, November 17, 2023
8:00 AM - 10:00 AM
Marriott Grand Ballroom 5-7
Medical
Moderators:
Jasper Bash, MD, Serge Carrier, MD, FRCS(C), MMgmt & Peter Tsambarlis, MD
8:00 AM - 8:10 AM
Recent Literature Summary
Speaker:
Jeffrey Morrison, MD
8:10 AM - 8:25 AM
The Challenge of Managing Low Sexual Desire in Patients with Cancer: The Impact of Cancer and Cancer Treatments
Speaker:
Andrew Matthew, PhD. C.Psych
8:25 AM - 8:40 AM
The Relationship of Erectile Dysfunction and Peyronie's Disease
Speaker:
Jonathan Clavell Hernandez, MD, FACS
8:40 AM - 8:55 AM
New Research on Androgen Receptors in the Vulvar Tissue
Speaker:
Alyssa Yee, MD
8:55 AM - 9:10 AM
Resident Autonomy in Urology and Sexual Medicine
Speaker:
Hossein Sadeghi-Nejad, MD
9:10 AM - 9:25 AM
Delayed or Inhibited Orgasm - The Mental Health Perspective
Speaker:
Michael Perelman, PhD
9:25 AM - 9:40 AM
Nanoparticles: Topical Delivery of Erectogenic Agents
Speaker:
Kelvin Davies, PhD
9:40 AM - 10:00 AM
Debate: Collagenase Clostridium Histolyticum Has a Role in Treating Peyronie's Disease with Concomitant EDs
Speakers:
Marah Hehemann, MD & Jesse Mills, MD
Saturday, November 18, 2023
1:30 PM - 2:30 PM
Rancho Santa Fe
Abstract Session - Peyronie's Disease
Moderators:
William Brant, MD, FACS, FECSM, Annie Imbeault, MD & David Miller, MD
1:30 PM - 1:36 PM
Efficacy and Safety of Platelet-Rich Plasma Injections for Peyronie’s Disease: A Randomized Double-Blind Placebo-Controlled Cross-Over Study (#112)
Speaker:
Braian Ledesma
1:36 PM - 1:42 PM
A Novel 3D Cellular Model for Peyronie's Disease Treatment Screening: PD.SPHERE (#113)
Speaker:
Wongsakorn Kiattiburut
1:42 PM - 1:48 PM
Mathematical Model for Peyronie's Disease (#114)
Speaker:
Bruno Machado
1:48 PM - 1:54 PM
Side Effect Profile of Collagenase Clostridium Histolyticum for Peyronie’s Disease Significantly Affects Long-term Patient Satisfaction (#115)
Speaker:
Jeffrey Song
1:54 PM - 2:00 PM
Breaking the Silence: Should I Be Concerned About Penile Fracture when Injecting Collagenase Clostridium Histolyticum? (#116)
Speaker:
Jake Miller
2:00 PM - 2:06 PM
Interrater Agreement and Feasibility of Three-Dimensional Photography for Curvature Assessment in Peyronie's Disease (#117)
Speaker:
Samantha L. Thorogood
2:06 PM - 2:12 PM
Clinical Predictors of Long-Term Satisfaction with Treatment of Collagenase Clostridium Histolyticum for Patients with Peyronie’s Disease (#118)
Speaker:
Jeffrey Song
2:12 PM - 2:18 PM
Impact of Ethnicity on Clinical Outcomes of Intralesional CCH in Peyronie's Disease Patients Across Kaiser Permanente Southern California Database (#119)
Speaker:
Hossein Mirheydar
2:18 PM - 2:24 PM
A Survey of Exposure to the Use of Xiaflex for the Treatment of Peyronie’s Disease Among United States Urology Residency Programs (#120)
Speaker:
Justin Loloi
2:24 PM - 2:30 PM
Utilizing ChatGPT for Urology Trainee Simulation of Peyronie’s Disease Counseling (#121)
Speaker:
Sharath Reddy
1:30 PM - 3:30 PM
Marriott Grand Ballroom 5-7
Innovation & Sexual Medicine (non-CME)
Moderators:
Gerard Henry, MD, Jason Jameson, MD & Catherine McMartin
1:30 PM - 1:50 PM
PDE-5 Inhibitors and Cardiac Health: Findings and Recommendations from the 4th Princeton Consensus Conference
Speakers:
Tobias Kohler, MD, MPH, Martin Miner, MD & Sharon Parish, MD
1:50 PM - 1:56 PM
Preservation of Sexual Function: 12-month Outcomes from a Randomized, Double-Blind, Sham Controlled Study Evaluating the Optilume BPH System, a Novel Drug Coated Balloon (#122)
Speaker:
Kevin Mcvary
1:56 PM - 2:02 PM
Preliminary Efficacy of Sildenafil Cream, 3.6% in an Exploratory, Randomized, Placebo-Controlled, Phase 2b Trial for the Treatment of Female Sexual Arousal Disorder (#123)
Speaker:
Andrew Goldstein
2:02 PM - 2:08 PM
An Open-Label, Vulvoscopic Pilot Study of Intravaginal Prasterone in Menopausal Women with Dyspareunia Examining Vestibular Tissue Changes (#124)
Speaker:
Sue W Goldstein
2:08 PM - 2:14 PM
Measurement of Clitoral Pulse Amplitude with a Wearable Device (#125)
Speaker:
Ashley Winter
2:14 PM - 2:20 PM
Application of HIFEM Therapy Improves Orgasmic, Urinary and Erectile Function by Stimulation of Pelvic Floor Muscles (#126)
Speaker:
Judson Brandeis
2:20 PM - 2:26 PM
Sexual Health Implications Associated with Psychotropic Medication Use Among Adolescents During the COVID-19 Pandemic (#127)
Speaker:
Armin Ghomeshi
2:26 PM - 2:32 PM
Characterizing Antibiotic Susceptibility of the Penile Prosthesis Microbiome (#128)
Speaker:
Bradley Roth
2:32 PM - 2:38 PM
Prophylactic Dips and Irrigation Solutions Can Considerably Alter the Antimicrobial Efficacy of Inflatable Penile Implant Hydrophilic Surface Coatings (#129)
Speaker:
Sohan Shah
2:38 PM - 2:44 PM
Antibiotic Solutions are the Ideal Irrigation Choice for Inflatable Penile Implant Hydrophilic Surfaces (#130)
Speaker:
Brian Im
2:44 PM - 2:50 PM
Predictors of Success with Early Antibiotic Therapy for Penile Implant Infection: Patients from a Prospective Randomized Study Comparing DNA Sequencing versus Traditional Cultures (#131)
Speaker:
Andrew Stuart
2:50 PM - 2:56 PM
Comparing the Frequencies of Different Species Present in Revision Penile Prostheses Surgery due to Infectious or Non-Infectious Causes (#132)
Speaker:
Caroline Henry
2:56 PM - 3:02 PM
Investigating Actinidin as a Potential Collagenase on Human Peyronie’s Disease Cells (#133)
Speaker:
Wongsakorn Kiattiburut
3:02 PM - 3:08 PM
Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie’s Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study (#134)
Speaker:
Bryce Palmer
3:08 PM - 3:14 PM
A Randomized Survey Study Comparing the Preference and Effectiveness of Two Different Penile Constriction Devices (#135)
Speaker:
Daniela Orozco Rendon
3:14 PM - 3:20 PM
Development and Evaluation of a Novel Penile Blood Oxygen Sensor for Assessing Tissue Oxygenation (#136)
Speaker:
Gal Saffati
3:20 PM - 3:26 PM
Sealed Vasectomy Procedure Prior Studies and Now Good Laboratory Practices FDA Study: Human, Porcine, Canine and Rabbit Subjects (#137)
Speaker:
Gerard Henry, MD
3:30 PM - 4:00 PM
Marriott Grand Ballroom Foyer - Poster Station 2
E-poster Session 20 - Miscellaneous
Moderator:
Jeffrey Campbell, MD, MPH, FRCSC
3:30 PM - 3:33 PM
Potential Effectiveness of Focused Vibration Treatment for Psychogenic Erectile Dysfunction: A Case Series (#366)
Speaker:
Jesus Eugenio Rodriguez
3:33 PM - 3:36 PM
Penile Constriction Device Satisfaction: Does Sexual Preference Have Any Effect on Preferences and Effectiveness? (#367)
Speaker:
Daniela Orozco Rendon
3:36 PM - 3:39 PM
Real World Survey Study to Explore the Effects of Flibanserin in Men with Sexual Dysfunction (#368)
Speaker:
Jonathan Clavell-Hernandez
3:39 PM - 3:42 PM
Physician Insights into the Safety of Flibanserin for the Treatment of Sexual Dysfunction in Men (#369)
Speaker:
Jonathan Clavell-Hernandez
3:42 PM - 3:45 PM
Overview of Nonclinical Studies of LIB-01, a Novel Promising Oral Drug Under Development for Treatment of Erectile Dysfunction (#370)
Speaker:
Francois Giuliano, MD, PhD
3:45 PM - 3:48 PM
Comparison of Collagenase Clostridium Histolyticum to Surgery for the Management of Peyronie’s Disease: A Randomized Trial – 1 Year Outcomes (#371)
Speaker:
Henry Larson
3:48 PM - 3:51 PM
Clinical Understanding Through Real-World Data to Validate Effectiveness of Treatments in Peyronie’s Disease (CURVE-PD): Registry Design (#372)
Speaker:
Jill Davis
3:51 PM - 3:54 PM
Economic Benefits of Patient Care for Prostate Cancer Survivors with Stress Urinary Incontinence and/or Erectile Dysfunction: A Physician Reimbursement Analysis (#373)
Speaker:
Paurush Babbar
3:54 PM - 3:57 PM
Comparing the Species Richness in Infectious versus Mechanical Failure Cases in Secondary Penile Prostheses Surgeries (#374)
Speaker:
Caroline Henry
3:57 PM - 4:00 PM
Assessing Infertility Literacy and Knowledge Gaps Amongst Patients with Cystic Fibrosis (#375)
Speaker:
Aymara Evans
3:30 PM - 4:00 PM
Marriott Grand Ballroom Foyer - Poster Station 5
E-poster Session 23 - Male Medical
Moderator:
Kelli Gross, MD
3:30 PM - 3:33 PM
Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men with Ventral Curvatures (#395)
Speaker:
Henry Larson
3:33 PM - 3:36 PM
Comparing Phone Based 3D Scanning App to In-Office Measurements to Assess Peyronie's Deformity (#396)
Speaker:
Adrianna Lee
3:36 PM - 3:39 PM
Investigating the Psychological Bother and Depression Among Gay Men with Peyronie's Disease (#397)
Speaker:
Ahmed Elshafei
3:39 PM - 3:42 PM
The Correlates of Satisfaction with Long-term Outcomes Following Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease (#398)
Speaker:
Jeffrey Song
3:42 PM - 3:45 PM
Reducing Out-of-Pocket Expenses for Peyronie’s Disease Therapy with a Novel Penile Traction Device (#399)
Speaker:
Lauren Dori
3:45 PM - 3:48 PM
Geographic Disparity in Collagenase Clostridium Histolyticum Utilization: A National Population-Based Analysis (#400)
Speaker:
Elie Kaplan-Marans
3:48 PM - 3:51 PM
Treatment Utilization and Temporal Trends in Peyronie’s Disease: A Retrospective Analysis of an Insurance Claims Database (#401)
Speaker:
Cameron Shonnard
3:51 PM - 3:54 PM
Peyronie's Disease Treatment- Active Vs. Stable Phase- Retrospective Review of Cases (#402)
Speaker:
Jonathan Gal
3:54 PM - 3:57 PM
Pilot Study: Fractional CO2 Laser in the Treatment of Chronic Phase Peyronie’s Disease (#403)
Speaker:
Abdullah Alhamam
3:57 PM - 4:00 PM
National Trends of Penile Fracture Encounters 2016-2019 (#404)
Speaker:
Joseph Marte
4:00 PM - 5:30 PM
Rancho Santa Fe
Abstract Session - Male Surgical
Moderators:
Denise Asafu-Adjei, MD, Tobias Kohler, MD, MPH & Thairo Pereira, MD
4:00 PM - 4:06 PM
Penile Plication is Well Tolerated Under Conscious Sedation: A Prospective Comparison of Deep Intravenous Vs. Nursing Administered Conscious Sedation (#167)
Speaker:
Dhiraj Bal
4:06 PM - 4:12 PM
Downgrading Surgical Recommendations After Intralesional Injections of Collagenase Clostridium Histolyticum in Peyronie’s Disease Patients (#168)
Speaker:
Lisa Hata
4:12 PM - 4:18 PM
New Findings Regarding the Degree of Penile Curvature Correction with IPP Alone (#169)
Speaker:
Britney Atwater
4:18 PM - 4:24 PM
Satisfaction with Penile Prosthesis Implantation among Patients with Peyronie’s Disease Using a Contemporary Questionnaire (#170)
Speaker:
Vivian Hua
4:24 PM - 4:30 PM
The Effects of Pretreatment with Xiaflex on Penile Curvature Correction with Manual Modeling During and After IPP placement (#171)
Speaker:
Britney Atwater
4:36 PM - 4:42 PM
Initial Experience with ReSheyP Device for Intraoperative Modeling of Peyronie’s Disease After Placement of a Penile Prosthesis (#173)
Speaker:
Elsayed Desouky
4:42 PM - 4:48 PM
Use of Penuma® for Correction of Residual Deformity following Previous Treatment of Peyronie’s disease: Case Series (#174)
Speaker:
Elsayed Desouky
4:48 PM - 4:54 PM
Shorter Duration of Postop IPP Inflation Following Manual Modeling May Lead to Curvature Regression (#175)
Speaker:
Britney Atwater
4:54 PM - 5:00 PM
Prior Intracavernosal Injection Therapy and Prostate Cancer Treatment are Both Independently Associated with Increased Risks of Complications in Men Undergoing Inflatable Penile Prosthesis Placement (#176)
Speaker:
Jake Miller
5:00 PM - 5:06 PM
Androgen Deprivation Therapy Does Not Increase Rates for Reintervention, Complication, or Infection in Penile Implant or Artificial Urinary Sphincter Surgery (#177)
Speaker:
Aaron Hochberg
5:06 PM - 5:12 PM
Exploring Intraoperative and Postoperative Penile Prosthetic Complications in the Solid Organ Transplant Population: A Propensity-Score Matched Analysis (#178)
Speaker:
John Johnson
5:12 PM - 5:18 PM
Does Climate Impact IPP Infection Risk? Assessment of Temperature and Dew Point on IPP Infections (#179)
Speaker:
Eliad Amini
5:18 PM - 5:24 PM
Unveiling Consumer Interest and Regional Disparities: Comparative Analysis of Online Search Trends for Penile Aesthetic Procedures (#180)
Speaker:
Muhammed A Moukhtar Hammad
5:24 PM - 5:30 PM
Prior Radiation Therapy is Associated with Increased Risk of Intra-Operative Complications in Patients Undergoing Primary Inflatable Penile Prosthesis Placement: Results from a Large Multi-Institutional Collaborative (#181)
Speaker:
Zafardjan Dalimov
